SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sungold Capital to acquire proprietary firm Onix Pharmaceuticals

29 Mar 2012 Evaluate

Sungold Capital’s board of directors has approved the proposal to acquire the proprietary firm Onix Pharmaceuticals engaged in pharmaceutical business, as a going concern. However, the company, which will now be division of Sungold Capital, continue its business in the name and style as “Onix Pharmaceuticals”. The company’s board of directors in their meeting held on March 29, 2012, approved the same.

Sungold Capital operates in the three distinct areas of media & entertainment, trading and finance. The company’s focus is to build further upon the success of its maiden release of the Hindi feature film 'Kya Hum Zinda Hain' through Sungold Entertainment, its media and entertainment division.

Sungold Capital Share Price

3.40 0.02 (0.59%)
17-Apr-2026 16:59 View Price Chart
Peers

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×